Health Subcommittee Holds Health Legislative Hearing on Enhancing Seniors’ Access to Breakthrough Medical Technology

WASHINGTON, D.C. - Today, Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, led a legislative hearing on examining policies to enhance seniors' access to breakthrough medical technologies.

"These policies are essential to reducing regulatory barriers to help patients get timely access to care, while also bringing more transparency into the coverage process at CMS," said Chairman Griffith. "It is our job as Congress to ensure that patients are able to access treatments, screenings, or devices in a timely manner-especially if there are no other alternatives on the market."

Watch the full hearing here.

Below are key excerpts from today's hearing:

Congresswoman Diana Harshbarger (TN-01) on the bill To amend title XVIII of the Social Security Act to ensure transparency in the national coverage determination process under the Medicare program and to make certain adjustments to Medicare local coverage determinations: "My question is, how should Medicare prioritize coverage pathways for therapies that address these high burden diseases?" Dr. Brinton: "As I said, this is obviously a huge number of Medicare beneficiaries [that] suffer from cardiovascular disorders. Ultimately, as we mentioned before, transitional coverage-the [Transitional Coverage for Emerging Technologies] as we exist today-provides an opportunity, but it's limited basically to five technologies. This is a pace that requires [Coverage with Evidence Development] to get to a national coverage decision, but there's an opportunity for a lot more than that to broaden the capability. There are technologies that we need to have available to seniors. The opportunity to do that basically provides accelerating this process."

Congressman John Joyce, M.D. (PA-13) on the Ensuring Patient Access to Critical Breakthrough Products Act of 2025: "Innovation has long been the cornerstone of American medicine. It's how I practiced medicine for 25 years. America has consistently led the world in development of new and innovative therapies and cutting-edge medical devices. However, due to the current payment structure of Medicare, our nation's seniors frequently can be excluded from accessing the newest medical device technology. In fact, this delay in coverage following an FDA approval by CMS has the unfortunate name of the valley of death."

Congresswoman Mariannette Miller-Meeks (IA-01) on the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act: "Late-stage cancer diagnoses are the deadliest, require treatments that take the hardest toll on patients, and cost the most to treat. That's why I was proud to coauthor the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act with my colleagues Representative Hudson, Arrington, Sewell, Ruiz, and Kelly. This critical legislation gives CMS the authority to cover multi-cancer early detection tests once they're approved by the FDA, ensuring our nation's seniors have access to groundbreaking innovation that will transform how we diagnose and prevent cancer progression."

###